Intellectual Property India Publishes Patent Application for 'Co-Crystals Of 4-[4-[3-Chloro-4-[1-(2-Pyridyl)-2-Hydroxy-Ethoxy]Pyrazolo[1,5-A]Pyridin-6-Yl]-5-Methyltriazol-1-Yl]Piperidine-1 -Carbonitrile Derivatives With Gallic Acid And Nicotine Amide' Filed by Eli Lilly And Company

MUMBAI, India, April 11 -- Intellectual Property India has published a patent application (202517027596 A) filed by Eli Lilly And Company, Indianapolis, on March 25, for 'co-crystals of 4-[4-[3-chloro-4-[1-(2-pyridyl)-2-hydroxy-ethoxy]pyrazolo[1,5-a]pyridin-6-yl]-5-methyltriazol-1-yl]piperidine-1 -carbonitrile derivatives with gallic acid and nicotine amide.'

Inventor(s) include Coates, David Andrew; Hilden, Lori Raquel; Kuminek, Gislaine; and Peterson, Jeffrey A.

The application for the patent was published on April 11, under issue no. 15/2025.

According to the abstract released by the Intellectual Property India: "The present invention relates to cocrystalline forms of 4-[4-[3- chloro-4-[l-(5-fluoro-2-pyridyl)-2-hydroxy-ethoxy]pyrazolo...